The present invention describes the usefulness of synthesizing anti-drug resistance inhibitor-mediated beta-lambda alpha kappa alpha__by injection of beta-lambda alpha kappa alpha__. It is suitable for applications in medicine. The present invention relates to a pharmaceutical composition comprising (usually ceftriaxone sodium kappa a zeta_) and_lambda alpha kappa_ (usually sodium_lambda alpha kappa_).The composition is useful in revealing that inpatients with intramuscular or intravenous antibiotics suffer from severe illness Infection.Specifically, the present invention relates to a pharmaceutical composition further comprising a chelating agent of alpha mu_kappa alpha P beta_zeta_lambda kappa_acid, e.g., ethylbenzene ENO ethylenediamine tetra acetic acid (EDTA), two or pharmaceutically acceptable salt.Determination of the enhanced strength of the pharmaceutical composition of the present invention The formation of particles in solution is usually_rho_gamma_theta S injection. The invention also provides a detailed dose form to be kept in a sealed container before being used as a supplement. The invention also provides for the preparation of these configurations.The method provided by the invention treats patients with diseases or disorders, and appropriate treatment and_lambda beta a-kappa_sodium ceftriaxone sodium.
展开▼